Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.185 USD | +1.43% |
|
-10.78% | -55.52% |
May. 15 | Sector Update: Health Care Stocks Advance in Afternoon Trading | MT |
May. 15 | CASI Pharmaceuticals Gets FDA Clearance For Blood Disorder Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.52% | 40.79M | |
+47.59% | 779B | |
+40.67% | 631B | |
-6.87% | 354B | |
+20.09% | 333B | |
+8.20% | 301B | |
+16.83% | 249B | |
-1.31% | 216B | |
+10.73% | 214B | |
+4.33% | 163B |
- Stock Market
- Equities
- CASI Stock
- News CASI Pharmaceuticals, Inc.
- HC Wainwright Lowers CASI Pharmaceuticals' Price Target to $12 From $30, Buy Rating Maintained